Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.

CHE is associated with disease progression and poor survival in patients with cirrhosis, which indicates that CHE could serve as an independent predictor of poor prognosis among patients with cirrhosis. This article is protected by copyright. All rights reserved.